Sodium Hyaluronate(Shinpoong)

透明质酸钠(Shinpoong)

Report date: 2024/07/26 10:01:31

Base Information

Drug NameSodium Hyaluronate(Shinpoong)
Drug Alias NameSP-5M-002SP5M002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHyaluronic acid replacements
TargetsHyaluronic acid
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A